查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1677321

维生素输注治疗产品市场按产品类型、配方类型、最终用户和应用划分 - 2025 年至 2030 年全球预测

Vitamin IV Therapy Product Market by Product, Type of IV Therapy, Formulation Type, End-User, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

维生素输注治疗产品市场预计在 2024 年价值为 31.2 亿美元，在 2025 年达到 33.5 亿美元，复合年增长率为 7.71%，到 2030 年达到 48.8 亿美元。

主要市场统计数据
基准年 2024 年 31.2亿美元
预计 2025 年 33.5亿美元
预测年份 2030 48.8亿美元
复合年增长率（%） 7.71％

作为传统营养补充和健康策略的可行替代方案，静脉注射维生素疗法市场正在迅速普及。在当今充满活力的医疗保健环境中，静脉注射维生素疗法不仅因其快速补水和营养的潜力而获得认可，而且还作为改善全身健康的创新方法。随着消费者的意识越来越强，生活方式的要求也越来越高，将维生素和其他有益成分直接注射到血液中代表着现代科学与以患者为中心的护理的交汇。

本介绍概况了推动市场成长的关键因素，包括不断变化的消费者偏好和整体健康实践日益增长的重要性。旨在最大限度地提高吸收率并最大限度减少对消化器官系统的干扰的输送机制已经引起了医疗专业人士和健康爱好者的注意。静脉注射维生素疗法有多种剂型，从医学增强输液到更随意的补液疗法，正成为健康产业的重要参与者。

对快速、有效的预防护理的持续追求正在推动该领域的研究、创新和产品改进，为我们治疗患者的方式的转变奠定基础。这种主动的转变将使相关人员能够及时、有效且科学地重新制定预防和恢復方案。

变革性变化重新定义维生素输注治疗市场格局

近年来，一系列变革正在显着地重新定义静脉注射维生素疗法的市场模式。这种转变正在刺激各个健康和福利领域的市场快速扩张和服务多样化。新的创新不仅限于改进配方，还强调个人化医疗策略的采用趋势。

製药和保健行业的技术进步促进了新型输送系统的开发，从而最大程度地提高生物有效性并减少潜在的副作用。因此，传统的膳食补充剂越来越多地被承诺快速见效和持久功效的输液溶液所补充。消费者也变得更加挑剔，越来越多地寻求能够立即改善体能、加快恢復速度并全面改善身心健康的治疗方法。

创新新兴企业和成熟企业都在重新考虑其产品开发策略，更加重视消费者的结果和现实利益。社会关注度的不断提高正推动市场相关人员投资强大的临床研究和先进的配方技术。因此，在曾经由传统保健品主导的静脉注射维生素疗法这一大类别中，出现了一个新市场。这种演变不仅使市场竞争更加激烈，也满足了注重健康的消费者群体的多样化需求。

关键细分洞察 了解市场多样性与消费者需求

透过基于关键细分指标的分析，对维生素输注疗法市场的洞察得到显着增强。例如，跨产品线的详细市场研究将描述药用和非药用选项，并阐明产品功效和消费者偏好。这种分类超越了基本的产品区分，深入研究了不同类型的输液治疗。这包括旨在解决明显衰老征兆的抗衰老输液疗法、专注于去除毒素的排毒输液疗法、补充体液的补液疗法以及旨在增强身体自然防御能力的免疫增强输液疗法。

此外，基于配方类型的分类区分了多组分配方和单组分配方。这种区分对于强调不同营养素之间的复杂性和潜在协同效应非常重要。市场分为多种类别，例如使用运动表现中心、家庭护理环境、医院和诊所以及健康和美容中心服务的人员。每个细分市场都有各自的营运动态和消费者期望。

我们基于应用的细分进一步细化了这些见解，研究了静脉注射维生素疗法如何应用于运动恢復和提高表现、慢性病管理、宿醉缓解和补水、增强免疫系统、支持心理健康和认知功能、体重管理策略以及整体健康和检验计划等场景。这些细分洞察可以让我们多方面了解市场趋势，并实现满足不同消费者需求的产品开发和行销。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 全球慢性病和文明病呈上升趋势
      • 与口服补充剂和药物相比，微创手术越来越受到青睐
      • 高端水疗中心和健康中心提供输液疗法，健康旅游迅速扩张
    • 限制因素
      • 缺乏足够的长期有效性临床证据
    • 机会
      • 透过为国际客户提供维生素 IV 治疗套餐来扩大医疗旅游业务
      • 开发维生素输注疗法以支持改善心理健康和认知功能
    • 任务
      • 消费者对静脉注射维生素疗法的认知与误解十分复杂
  • 市场区隔分析
    • 静脉注射疗法的类型：排毒静脉注射疗法正变得越来越流行，可以改善代谢平衡
    • 应用：扩大静脉注射维生素疗法在慢性病管理的应用
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会的
    • 技术的
    • 合法的
    • 环境

第 6 章维生素输注治疗产品市场（按产品）

  • 药用
  • 非药品

7. 维生素输注治疗产品市场（按静脉注射治疗类型）

  • 抗衰老 IV
  • 解毒 IV
  • 水化疗法
  • 免疫力增强剂 IV

8. 维生素输注治疗产品市场（依配方类型）

  • 多种成分配方
  • 单一成分配方

第九章维生素输注治疗产品市场（以最终用户划分）

  • 运动表现中心
  • 家庭护理设置
  • 医院和诊所
  • 健康与美容中心

第 10 章维生素输注治疗产品市场（按应用）

  • 运动恢復与表现
  • 慢性病管理
  • 缓解宿醉和补水疗法
  • 增强免疫系统
  • 心理健康与认知功能
  • 体重管理
  • 健康与復兴

11. 美洲维生素注射治疗产品市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太地区维生素输注治疗产品市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲维生素输注产品市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章 竞争格局

  • 2024 年市场占有率分析
  • FPNV 定位矩阵，2024 年
  • 竞争情境分析
  • 战略分析与建议

公司列表

  • Amanta Healthcare Limited
  • B. Braun SE
  • Baxter International Inc.
  • Boost IV
  • Core IV Therapy, LLC
  • Cryojuvenate UK Ltd
  • DaVita Inc.
  • Drip Hydration
  • Hydrate IV Bar Holdings, LLC
  • HYDRATION ROOM
  • IV League
  • JUST LIVV, INC
  • JW Life Science Corporation
  • Mobile IV Medics, Inc.
  • NexGen Health
  • Otsuka Pharmaceutical Co., Ltd.
  • PrimeIV Hydration & Wellness
  • Restore Franchising, LLC.
  • REVIV Global Ltd.
  • Revival IV Lounge
  • The IV Doc
  • The Wellness Co.
  • Unilever PLC
  • Vida-Flo USA
  • Vitamin IV Therapy, Inc.
Product Code: MRR-621635E2CBF7

The Vitamin IV Therapy Product Market was valued at USD 3.12 billion in 2024 and is projected to grow to USD 3.35 billion in 2025, with a CAGR of 7.71%, reaching USD 4.88 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 3.12 billion
Estimated Year [2025] USD 3.35 billion
Forecast Year [2030] USD 4.88 billion
CAGR (%) 7.71%

The market for vitamin IV therapy has rapidly gained traction as a viable alternative to traditional nutritional supplementation and wellness strategies. In today's dynamic healthcare environment, vitamin IV therapy is being recognized not only for its potential to provide immediate hydration and nutrient replenishment but also as an innovative approach to enhancing overall well-being. As consumer awareness increases and lifestyles become increasingly demanding, the infusion of vitamins and other beneficial compounds directly into the bloodstream represents an intersection of modern science and patient-centric care.

This introduction provides an overview of the key elements driving market growth, including evolving consumer preferences and the rising importance of holistic wellness practices. The delivery mechanism, designed to maximize absorption and minimize digestive interference, is capturing the attention of both medical professionals and wellness enthusiasts. With diverse formulations available, ranging from medically enhanced infusions to more casually oriented hydration therapies, vitamin IV therapy is becoming a significant player in the wellness industry.

The ongoing pursuit for rapid and effective preventive care continues to drive research, innovation, and product improvements in this segment, setting the stage for transformative changes in treatment modalities. This proactive shift allows stakeholders to reimagine prevention and recovery in a timely, efficient, and scientifically sound manner.

Transformative Shifts Redefining the Vitamin IV Therapy Market Landscape

Recent years have witnessed a series of transformative shifts that have significantly redefined the vitamin IV therapy market landscape. These shifts are now fueling rapid market expansion and the diversification of service offerings across various health and wellness sectors. Emerging innovations are not just confined to formulation improvements but also extend to adoption trends that emphasize personalized healthcare strategies.

Technological advancements in the pharmaceutical and wellness industries have led to the development of new delivery systems that maximize bioavailability and mitigate potential side effects. As a result, traditional nutritional supplements are increasingly being complemented by IV solutions that promise quick results and sustained benefits. Consumers are now more discerning, often seeking therapies that offer immediate performance enhancement, rapid recovery, and an all-encompassing approach to physical and mental well-being.

Innovative startups and established companies alike are now recalibrating their product development strategies, placing a stronger emphasis on consumer outcomes and real-world efficacy. As public interest grows, market players are investing in robust clinical research and sophisticated formulation techniques. This has led to the emergence of niche sectors within the broad category of vitamin IV therapy, which were once predominantly dominated by conventional wellness supplements. Through this evolution, the market has not only become more competitive but also more attuned to the diversified needs of a health-conscious consumer base.

Key Segmentation Insights: Understanding Market Variation and Consumer Needs

Insight into the vitamin IV therapy market is greatly enhanced by an analysis based on key segmentation metrics. A detailed study of the market across product lines, for instance, recognizes the distinct characteristics of medicated versus non-medicated options, thereby providing clarity on product efficacy and consumer preferences. The categorization extends beyond basic product differentiation as it dives into the specifics of various types of IV therapy. This includes anti-aging IV treatments aimed at combating the visible signs of aging, detoxification IV therapies that focus on the removal of toxins, hydration therapy that replenishes bodily fluids, and immune boosting IV interventions designed to strengthen the body's natural defenses.

Furthermore, the segmentation based on formulation type distinguishes multi-ingredient formulations from single-ingredient ones. Such differentiation is significant in highlighting the varying complexity and potential synergies among different nutrients. It also paves the way for tailored therapies in connection with end-user profiles, where the market is segmented into categories such as those using services at athletic performance centers, homecare settings, hospitals and clinics, and wellness as well as aesthetic centers. Each of these segments carries its own set of operational dynamics and consumer expectations.

The application-based segmentation further refines these insights, examining how vitamin IV therapy is utilized in contexts such as athletic recovery and performance improvement, the management of chronic diseases, hangover relief coupled with hydration benefits, immune system enhancement, mental health and cognitive function support, weight management strategies, and comprehensive wellness and rejuvenation programs. Together, these segmentation insights offer a multidimensional view of market trends and ensure that product development and marketing efforts are finely tuned to meet diverse consumer demands.

Based on Product, market is studied across Medicated and Non-medicated.

Based on Type of IV Therapy, market is studied across Anti-Aging IV, Detoxification IV, Hydration Therapy, and Immune Boosting IV.

Based on Formulation Type, market is studied across Multi-Ingredient Formulations and Single-Ingredient Formulations.

Based on End-User, market is studied across Athletic Performance Centers, Homecare Settings, Hospitals & Clinics, and Wellness & Aesthetic Centers.

Based on Application, market is studied across Athletic Recovery & Performance, Chronic Disease Management, Hangover Relief & Hydration Therapy, Immune System Boosting, Mental Health & Cognitive Function, Weight Management, and Wellness & Rejuvenation.

Key Regional Insights Driving Global Growth and Market Penetration

The global footprint of vitamin IV therapy is notably marked by its varied adoption across different regions, each exhibiting unique market dynamics. For instance, in the Americas, there exists a strong culture of innovation supported by robust healthcare infrastructure and a fast-growing wellness community. This has fostered a supportive environment for the adoption of advanced therapeutic solutions that align with modern lifestyles and preventive health strategies.

In the combined regions of Europe, the Middle East, and Africa, a noticeable trend is the rising shift towards integrative therapies and personalized treatment protocols. These regions display a growing demand for products that are not only effective but also adhere to strict regulatory standards. Consumers here often seek therapies that offer both aesthetic and functional benefits, driving innovation in product formulations and treatment methodologies.

Asia-Pacific stands out with its rapid development, influenced by a combination of traditional wellness practices and modern medical research. The region is witnessing an accelerated rate of urbanization and rising consumer incomes, factors which contribute to a greater willingness to invest in premium health and wellness services. Together, these regional insights not only reflect diverse market penetration strategies but also underscore the importance of a localized approach to consumer engagement and product deployment.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Key Companies Insights: Market Leaders and Innovators Pioneering Growth

A closer examination of the key companies in the vitamin IV therapy market reveals a concentration of both established industry giants and nimble innovators who are playing influential roles in shaping the market agenda. Industry leaders, such as Amanta Healthcare Limited, B. Braun SE, and Baxter International Inc., are leveraging their extensive networks and research capabilities to push the boundaries of what vitamin IV therapy can achieve. Complementing these traditional players are innovative firms like Boost IV, Core IV Therapy, LLC, and Cryojuvenate UK Ltd, which have rapidly gained attention due to their agile response to consumer trends and advanced proprietary treatment protocols.

Other notable players include DaVita Inc. and Drip Hydration, whose operational expertise in managing healthcare and hydration networks has provided them a competitive edge in market dynamics. Companies such as Hydrate IV Bar Holdings, LLC, HYDRATION ROOM, and IV League are also at the forefront, innovating with customized solutions that resonate with specific demographic segments. The participation of emerging brands such as JUST LIVV, INC and JW Life Science Corporation further highlights the diversification potential of this market.

Moreover, there is a significant contribution from Mobile IV Medics, Inc., NexGen Health, and international entities like Otsuka Pharmaceutical Co., Ltd. These organizations are thriving in an environment driven by continuous clinical validation and consumer interest in on-demand wellness solutions. PrimeIV Hydration & Wellness, Restore Franchising, LLC., REVIV Global Ltd., Revival IV Lounge, The I.V. Doc, The Wellness Co., Unilever PLC, Vida-Flo USA, and Vitamin IV Therapy, Inc. collectively illustrate the relentless push for market excellence and the critical role of strategic innovation in sustaining competitive advantage across the industry.

The report delves into recent significant developments in the Vitamin IV Therapy Product Market, highlighting leading vendors and their innovative profiles. These include Amanta Healthcare Limited, B. Braun SE, Baxter International Inc., Boost IV, Core IV Therapy, LLC, Cryojuvenate UK Ltd, DaVita Inc., Drip Hydration, Hydrate IV Bar Holdings, LLC, HYDRATION ROOM, IV League, JUST LIVV, INC, JW Life Science Corporation, Mobile IV Medics, Inc., NexGen Health, Otsuka Pharmaceutical Co., Ltd., PrimeIV Hydration & Wellness, Restore Franchising, LLC., REVIV Global Ltd., Revival IV Lounge, The I.V. Doc, The Wellness Co., Unilever PLC, Vida-Flo USA, and Vitamin IV Therapy, Inc.. Actionable Recommendations for Industry Leaders to Drive Strategic Growth

For industry leaders aiming to solidify their position in the dynamic vitamin IV therapy market, a multifaceted approach that balances innovation with market responsiveness is essential. Firstly, investment in comprehensive research and development efforts is crucial. Companies should prioritize studies that validate the clinical efficacy of various formulations while exploring opportunities to enhance product delivery mechanisms through state-of-the-art technology. This proactive approach can lead to breakthrough enhancements that address specific market needs.

In addition to R&D, leveraging partnerships with academic and clinical institutions can provide insightful data and a strong foundation for product development. Fostering relationships with research bodies can also facilitate timely access to emerging scientific findings and contribute to the design of next-generation IV therapies that are both safe and effective. Furthermore, strategic market diversification is recommended: companies should consider extending their portfolios to include both medicated and non-medicated options to cater to varying consumer preferences.

Enhancing digital infrastructure for customer outreach and engagement remains vital. By deploying advanced digital marketing strategies and robust e-commerce platforms, companies can effectively communicate product benefits and reach a broader audience. With the integration of personalized data and consumer feedback, it is possible to refine marketing strategies and product offerings continuously.

Operational excellence and agility in supply chain management are other critical factors. Efficient distribution networks and advanced inventory management systems can deliver competitive advantage, especially in regions with diverse regulatory landscapes. In all, industry leaders must adopt a customer-centric approach, ensuring that product innovation, market expansion, and operational strategies are seamlessly integrated to capture emerging opportunities in this vibrant market.

Conclusion: Embracing Innovation and Strategic Growth in Vitamin IV Therapy

In summary, the vitamin IV therapy market stands at a pivotal juncture, characterized by rapid innovation, evolving consumer preferences, and a resilient demand for efficient wellness solutions. The market's progression-from initial adoption to the integration of advanced technologies-illustrates the community's unwavering commitment to holistic care and scientific advancement.

With a wide array of segmentation insights shedding light on various product categories, therapy types, and application areas, stakeholders are equipped with the necessary information to drive targeted and effective strategies. Regional insights underline the importance of adapting approaches to suit the cultural and economic nuances of diverse markets, while company insights emphasize the role of strategic partnerships and agile innovation in navigating competitive pressures.

As this dynamic landscape continues to evolve, the necessity for industry players to focus on transparency, quality assurance, and consumer education remains paramount. Innovative therapies, bolstered by robust clinical data and a clear understanding of consumer needs, are well positioned to redefine traditional paradigms in health and wellness. Ultimately, a forward-thinking approach combined with a relentless pursuit of excellence will be the guiding force behind sustained market success.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increase in chronic diseases and lifestyle disorders globally
      • 5.1.1.2. Growing preference for minimally invasive treatments over oral supplements and medications
      • 5.1.1.3. Rapid expansion in wellness tourism with IV therapy offerings at upscale spas and wellness centers
    • 5.1.2. Restraints
      • 5.1.2.1. Lack of sufficient clinical evidence for long-term efficacy
    • 5.1.3. Opportunities
      • 5.1.3.1. Expanding presence in medical tourism by offering vitamin IV therapy packages for international clients
      • 5.1.3.2. Developing a line of vitamin IV therapies that support mental health and cognitive function improvements
    • 5.1.4. Challenges
      • 5.1.4.1. Complexities of consumer perception and misconceptions about vitamin IV therapy
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type of IV Therapy: Increasing preference for detoxification IV therapy for improving metabolic balance
    • 5.2.2. Application: Expanding application of vitamin IV therapy in chronic disease management
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Vitamin IV Therapy Product Market, by Product

  • 6.1. Introduction
  • 6.2. Medicated
  • 6.3. Non-medicated

7. Vitamin IV Therapy Product Market, by Type of IV Therapy

  • 7.1. Introduction
  • 7.2. Anti-Aging IV
  • 7.3. Detoxification IV
  • 7.4. Hydration Therapy
  • 7.5. Immune Boosting IV

8. Vitamin IV Therapy Product Market, by Formulation Type

  • 8.1. Introduction
  • 8.2. Multi-Ingredient Formulations
  • 8.3. Single-Ingredient Formulations

9. Vitamin IV Therapy Product Market, by End-User

  • 9.1. Introduction
  • 9.2. Athletic Performance Centers
  • 9.3. Homecare Settings
  • 9.4. Hospitals & Clinics
  • 9.5. Wellness & Aesthetic Centers

10. Vitamin IV Therapy Product Market, by Application

  • 10.1. Introduction
  • 10.2. Athletic Recovery & Performance
  • 10.3. Chronic Disease Management
  • 10.4. Hangover Relief & Hydration Therapy
  • 10.5. Immune System Boosting
  • 10.6. Mental Health & Cognitive Function
  • 10.7. Weight Management
  • 10.8. Wellness & Rejuvenation

11. Americas Vitamin IV Therapy Product Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific Vitamin IV Therapy Product Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa Vitamin IV Therapy Product Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. Hydreight Technologies partners with The DRIPBaR to launch DRIPBaR Direct as a nationwide direct-to-consumer platform for at-home IV therapy
    • 14.3.2. Cardone Ventures' 10X Health and REVIV Global launch a science-driven, genetically tailored IV therapy system to enhance precision nutrition in the UK
    • 14.3.3. Hydralive therapy secures USD 2.2 million growth funding to accelerate customized IV therapy and wellness services franchising
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Amanta Healthcare Limited
  • 2. B. Braun SE
  • 3. Baxter International Inc.
  • 4. Boost IV
  • 5. Core IV Therapy, LLC
  • 6. Cryojuvenate UK Ltd
  • 7. DaVita Inc.
  • 8. Drip Hydration
  • 9. Hydrate IV Bar Holdings, LLC
  • 10. HYDRATION ROOM
  • 11. IV League
  • 12. JUST LIVV, INC
  • 13. JW Life Science Corporation
  • 14. Mobile IV Medics, Inc.
  • 15. NexGen Health
  • 16. Otsuka Pharmaceutical Co., Ltd.
  • 17. PrimeIV Hydration & Wellness
  • 18. Restore Franchising, LLC.
  • 19. REVIV Global Ltd.
  • 20. Revival IV Lounge
  • 21. The I.V. Doc
  • 22. The Wellness Co.
  • 23. Unilever PLC
  • 24. Vida-Flo USA
  • 25. Vitamin IV Therapy, Inc.

LIST OF FIGURES

  • FIGURE 1. VITAMIN IV THERAPY PRODUCT MARKET MULTI-CURRENCY
  • FIGURE 2. VITAMIN IV THERAPY PRODUCT MARKET MULTI-LANGUAGE
  • FIGURE 3. VITAMIN IV THERAPY PRODUCT MARKET RESEARCH PROCESS
  • FIGURE 4. VITAMIN IV THERAPY PRODUCT MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. VITAMIN IV THERAPY PRODUCT MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. VITAMIN IV THERAPY PRODUCT MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. VITAMIN IV THERAPY PRODUCT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. VITAMIN IV THERAPY PRODUCT MARKET DYNAMICS
  • TABLE 7. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY MEDICATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY NON-MEDICATED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY ANTI-AGING IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY DETOXIFICATION IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY HYDRATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY IMMUNE BOOSTING IV, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY MULTI-INGREDIENT FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY SINGLE-INGREDIENT FORMULATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY ATHLETIC PERFORMANCE CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY WELLNESS & AESTHETIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY ATHLETIC RECOVERY & PERFORMANCE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY CHRONIC DISEASE MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY HANGOVER RELIEF & HYDRATION THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY IMMUNE SYSTEM BOOSTING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY MENTAL HEALTH & COGNITIVE FUNCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY WEIGHT MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY WELLNESS & REJUVENATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY TYPE OF IV THERAPY, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY FORMULATION TYPE, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM VITAMIN IV THERAPY PRODUCT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 240. VITAMIN IV THERAPY PRODUCT MARKET SHARE, BY KEY PLAYER, 2024
  • TABLE 241. VITAMIN IV THERAPY PRODUCT MARKET, FPNV POSITIONING MATRIX, 2024